Highlights of the advance prostate cancer session meeting in Orlando, Florida included Abstract 531 which evaluated 6,437 men who had received androgen deprivation therapy for more than 1.5 years. According to the abstract Dementia and COPD were the main non-GU side effects associated with long-term androgen deprivation. Presented by Ziya Kirkall, MD, at the Annual [...]
"All-cause mortality” or death by all causes has been shown to increase in men who have deficiencies of testosterone. A new study, conducted in Germany, recently came to this conclusion. In this study, The Study of Health in Pomerania (SHIP), the researchers looked at death rates from any cause in almost 2,000 men aged 20 [...]
Researchers at Weill Cornell Medical College, New York, have found the hormone estrogen plays a major role in about half of all prostate cancers. Their findings were published in the May 27 online edition of the Journal of the National Cancer Institute. They have found that the estrogen-linked signaling helps drive a discrete and aggressive [...]
A faulty gene closely associated with breast cancer is also responsible for a particularly dangerous form of prostate cancer, research has confirmed. The British Journal of Cancer reported a study that a University of Toronto research team found prostate cancer patients carrying the BRCA2 gene lived on average for four years after diagnosis as opposed [...]
I want to change pace a little today and instead of directly discussing advanced prostate cancer, I am going to discuss an issue that has been coming up in our community, universal prostate cancer screening. We have all been embattled in an on going dispute, a disagreement about the value of general prostate cancer screening. [...]